SVF ENDURANCE (CAYMAN) LTD sold 3.2% of their position (463.77K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $2.91M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/26/2025ACC: 0001493152-25-025161
10% Owner
Since Oct 2019
-463.77K
Net shares
Net seller
$2.91M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
463.77K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−227.80K
Price / share
$6.15
Trade value
$1.40M
% of position
1.6%
11/24/2025
14.57M→14.35M
Common Stock
Indirect
Shares
−235.97K
Price / share
$6.38
Trade value
$1.51M
% of position
1.6%
11/25/2025
14.35M→14.11M
Total
Net shares
−463.77K
Net value
-$2.91M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/24/2025 | S · Sale | −227.80K | $6.15 | $1.40M | 1.6% | 14.57M | 14.35M |
| Common Stock Indirect | 11/25/2025 | S · Sale | −235.97K | $6.38 | $1.51M | 1.6% | 14.35M | 14.11M |
| Total | −463.77K | -$2.91M | ||||||
Derivative Transactions0
No derivative transactions reported